Clinical Newsletter

Clinical Newsletter

Regular updates on our latest clinical studies.

Subscribe

Publicatie zoeken

Onze teams van Onderzoek en Ontwikkeling zijn wereldwijd werkzaam, en creëren synergieën met onze deskundigheid en verwante vakdisciplines. Wij wisselen internationaal veel van gedachten met onafhankelijke, gespecialiseerde instituten, belangrijke opinieleiders en kennisverspreiders om zo samenwerkings- en kennismanagement op het hoogste niveau te kunnen garanderen. In het kader daarvan voeren wij grote studies uit die voortdurend op congressen in de vorm van posters of lezingen van onze partners, op symposia en in workshops worden gepresenteerd, en ook in befaamde wetenschappelijke tijdschriften worden gepubliceerd. De voor het grootste deel door onafhankelijke deskundigen beoordeelde, op bewijs gebaseerde vakpublicaties stellen wij u graag in deze databank ter beschikking:

  1. Poster

    THE CARE OF PATIENTS WITH STAGNATING DIABETIC FOOT ULCERS USING A COLLAGEN DRESSING

    Poster presented at EWMA 2011 25.05.2011 Brussels, Belgium
    Products Suprasorb P
  2. Poster

    Treatment of a painful ulcer with an ionic sheet hydrogel dressing.

    Poster presented at EWMA 2011 25.05.2011 Brussels, Belgium
    Products Suprasorb X
    Further versions
  3. Poster

    TREATMENT WITH A COLLAGEN DRESSING OF TWO PATIENTS WITH STAGNATING SKIN LESIONS CAUSED BY IRRADIATION THERAPY

    Poster presented at EWMA 2011 25.05.2011 Brussels, Belgium
  4. Poster

    IS POLIHEXANIDE A NEW EFFECTIVE TREATMENT FOR INFECTED WOUNDS FOR FRANCOPHONE COUNTRIES?

    Poster presented at EWMA 2011 25.05.2011 Brussels, Belgium
    Further languages
  5. Poster

    The challenges of implementing new treatment regimes in a hospital setting.

    Poster presented at EWMA 2011 25.05.2011 Brussels, Belgium
  6. Poster

    Biocellulose wound dressing with PHMB* in the management of cutaneous lesions treated with dermic substitutes

    Poster presented at EWMA 2011 25.05.2011 Brussels, Belgium
    Further versions
  7. Poster

    Does the unqualified nurse have a role to play in the active recall and follow up care of patients with healed leg ulcers?

    Poster presented at EWMA 2011 25.05.2011 Brussels, Belgium
  8. Poster

    Anti-inflammatory effects of a collagen-containing wound dressing in a cell-based inflammation model in vitro

    Poster presented at EWMA 2011 25.05.2011 Brussels, Belgium
    Further versions
    Further languages
  9. Poster

    A national survey of the nursing practice in the treatment of hyperkeratosis associated with venous hypertension.

    Poster presented at EWMA 2011 25.05.2011 Brussels, Belgium
  10. Poster

    THE WOUND DEBRIDER –A NEW MONOFILAMENT FIBRE TECHNOLOGY: Results of a pilot study

    Poster presented at EWMA 2011 25.05.2011 Brussels, Belgium

    Introduction:

    Debridement is a basic necessity to induce the process of tissue repair especially in chronic wounds.

     

    Methods:

    In this prospective, blindly assessed pilot study we used a new debrider technology with specific monofilament fibres in a unique texture to evaluate its efficacy, safety and tolerability. In altogether 11 patients exhibiting all kinds of wound-associated debris (biofilms, slough, necrotic crusts, ‘hyperkeratotic’ plaques, see table 1) the debrider*, wetted with physiological solution, was wiped without specific force over the wound for about 2-4 minutes.

     

    Results:

    The debrider* removed almost all debris leaving healthy granulation tissue (including even small epithelialised islands of vital tissues) intact. (fig. 1 - 4) The patients didn’t feel adverse symptoms, in particular no pain. The healthcare professional’s global assessment revealed that the use of the debrider* was easy, fast and very efficient. Scanning electron microscopic analyses identified the majority of the removed debris tightly packed within the monofilament texture (fig. 5 and 6). Finally, a surgeon blindly assessed pictures of wounds (taken before / after the debridement), ranked all debridement results into the best category and one wound formerly classified for a need of surgical debridement as “equal to surgical debridement”.

     

    Conclusion:

    We have generated the basic proof of concept that the new debrider*-based technology is easy, fast, highly efficient, safe and well-tolerated. Further, since the new debrider* allows its broad use not only by specialised physicians but also by all healthcare professionals, it is anticipated that its use would save substantial costs. Hence, the new debrider* puts the need of other wound bed preparation procedures into question.

    Products Debrisoft Pad
    Further versions